.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Federal Trade Commission
Queensland Health
Fish and Richardson
Johnson and Johnson
Fuji
Medtronic
Boehringer Ingelheim
Merck

Generated: November 17, 2017

DrugPatentWatch Database Preview

IXEMPRA KIT Drug Profile

« Back to Dashboard

Which patents cover Ixempra Kit, and when can generic versions of Ixempra Kit launch?

Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in IXEMPRA KIT is ixabepilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ixabepilone profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► SubscribeY► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► SubscribeY► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► SubscribeY► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► SubscribeY► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► SubscribeY► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► SubscribeY► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
R-pharm Us Llc
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for IXEMPRA KIT

Drugname Dosage Strength RLD Submissiondate
ixabepilonInjection15 mg/vial and 45 mg/vial, single-use vialsIxempra Kit4/16/2012
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Argus Health
Harvard Business School
US Department of Justice
Medtronic
McKinsey
Accenture
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot